Walgreens Boots Alliance is willing to unload up to 1,000 stores in order to win regulatory approval of its $17.2 billion deal to acquire Rite Aid, the company said in a securities filing.
The cap represents about 8 percent of the combined company’s 12,700 U.S. stores.
The proposed merger of two of the three largest drugstore chains requires the approval of the Federal Trade Commission. Two influential U.S. senators have called for an examination of whether the deal would raise drug prices for consumers and reduce choice.
“I have fought tirelessly to promote competition in the health sector and I believe the proposed merger of two of the three largest drug store chains in the country raises serious issues,” Sen. Amy Klobuchar of Minnesota, the top Democrat on the Senate Judiciary Committee’s antitrust subcommittee, said in a statement this week.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Atkore Faces Shareholder Lawsuit Over Alleged Price-Fixing Scheme
Mar 19, 2025 by
CPI
US Appeals Court Upholds Ruling Denying Copyright for AI-Generated Art
Mar 19, 2025 by
CPI
Morrison Foerster Expands European Antitrust Practice
Mar 19, 2025 by
CPI
HSBC in Advanced Talks to Sell German Fund Unit to BlackFin Capital Partners
Mar 19, 2025 by
CPI
EU’s Antitrust War on Big Tech Heats Up as US Trade Disputes Grow
Mar 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Self-Preferencing
Feb 26, 2025 by
CPI
Platform Self-Preferencing: Focusing the Policy Debate
Feb 26, 2025 by
Michael Katz
Weaponized Opacity: Self-Preferencing in Digital Audience Measurement
Feb 26, 2025 by
Thomas Hoppner & Philipp Westerhoff
Self-Preferencing: An Economic Literature-Based Assessment Advocating a Case-By-Case Approach and Compliance Requirements
Feb 26, 2025 by
Patrice Bougette & Frederic Marty
Self-Preferencing in Adjacent Markets
Feb 26, 2025 by
Muxin Li